Editorial Comment to Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis
Standard
Editorial Comment to Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis. / Oing, Christoph.
In: INT J UROL, Vol. 28, No. 8, 08.2021, p. 847-848.Research output: SCORING: Contribution to journal › Editorial › Research
Harvard
Oing, C 2021, 'Editorial Comment to Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis', INT J UROL, vol. 28, no. 8, pp. 847-848. https://doi.org/10.1111/iju.14641
APA
Oing, C. (2021). Editorial Comment to Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis. INT J UROL, 28(8), 847-848. https://doi.org/10.1111/iju.14641
Vancouver
Oing C. Editorial Comment to Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis. INT J UROL. 2021 Aug;28(8):847-848. https://doi.org/10.1111/iju.14641
Bibtex
@article{1f5cd0059ed349e881bcd8ec8bb1d2c9,
title = "Editorial Comment to Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis",
author = "Christoph Oing",
year = "2021",
month = aug,
doi = "10.1111/iju.14641",
language = "English",
volume = "28",
pages = "847--848",
journal = "INT J UROL",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "8",
}
RIS
TY - JOUR
T1 - Editorial Comment to Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis
AU - Oing, Christoph
PY - 2021/8
Y1 - 2021/8
U2 - 10.1111/iju.14641
DO - 10.1111/iju.14641
M3 - Editorial
C2 - 34229358
VL - 28
SP - 847
EP - 848
JO - INT J UROL
JF - INT J UROL
SN - 0919-8172
IS - 8
ER -
